Financials

News Discussions Technicals Seasonals

TRU fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

TruScreen Group Ltd. engages in the development, manufacture, and sale of cancer detection device and systems. It offers Truscreen Cervical Cancer screening system, which is designed to detect the presence in real time of pre-cancerous and cancerous tissue on the cervix by using optical and electrical measurements of cervical tissue. The company was founded on November 6, 2013 and is headquartered in Auckland, New Zealand.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

TRU does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company